PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford (S.P., A.R.), the Department of Haematology, University College London Hospitals NHS Foundation Trust and Cardiometabolic Programme-National Institute for Health Research University College London Hospitals-Biomedical Research Centre (M.S., B.C.), the Thrombosis and Haemophilia Centre, Guy\'s and St. Thomas\' NHS Foundation Trust and King\'s College London (B.J.H.), and the Department of Statistical Science, University College London Hospitals NHS Foundation Trust (G.A.), London, the Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham (W.L.), the Department of Haematology, Glasgow Royal Infirmary, Glasgow (C.B.), and the Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield (M.M.) - all in the United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1056/NEJMoa2109908
?:doi
?:hasPublicationType
?:journal
  • The New England journal of medicine
is ?:pmid of
?:pmid
?:pmid
  • 34379914
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all